Table 1_Machine learning-based prediction of diabetic peripheral neuropathy: model development and clinical validation.docx

BackgroundDiabetic peripheral neuropathy (DPN) is a common and debilitating complication of type 2 diabetes mellitus (T2DM), significantly impacting patients’ quality of life and increasing healthcare burdens. Early prediction and intervention are critical to mitigating its impact.
MethodsThis study analyzed 1,544 diabetic patients from the First Affiliated Hospital of Shandong First Medical University, who were randomly divided into a training cohort (n = 1,082) and a testing cohort (n = 462) using a 7:3 split ratio. Feature selection was performed using both Boruta and LASSO algorithms, and the intersection of the selected variables was used as the final predictor set. Eight key predictors were identified from 23 variables, including diabetes duration, uric acid, HbA1c, NLR, smoking status, SCR, LDH, and hypertension. Nine machine learning models were developed and compared for DPN risk prediction.
ResultsStochastic Gradient Boosting (SGBT) demonstrated the best performance (training AUC: 0.933, 95% CI: 0.921–0.946; testing AUC: 0.811, 95% CI: 0.776–0.843). Shapley Additive Explanations (SHAP) analysis provided interpretability, highlighting the clinical importance of diabetes duration and HbA1c among other predictors.
ConclusionThis study establishes a robust predictive tool for early DPN detection, laying the foundation for improved prevention and management strategies.